GOHEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.15 USD | +1.40% |
|
-3.33% | -23.91% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 1,150 | 435 | 92.91 | 127.5 | 100.9 | - |
| Enterprise Value (EV) 1 | 1,406 | 1,021 | 586.5 | 127.5 | 100.9 | 100.9 |
| P/E ratio | -62.1 x | -2.12 x | -0.59 x | -1.86 x | -1.91 x | -2.29 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 1.31 x | 0.41 x | 0.15 x | 0.17 x | 0.14 x | 0.13 x |
| EV / Revenue | 1.31 x | 0.41 x | 0.15 x | 0.17 x | 0.14 x | 0.13 x |
| EV / EBITDA | 4.24 x | 12.9 x | -0.72 x | 1.7 x | 1.3 x | 1.18 x |
| EV / FCF | -8.93 x | -1.36 x | 1.96 x | - | 1.29 x | 1.08 x |
| FCF Yield | -11.2% | -73.3% | 51% | - | 77.8% | 93% |
| Price to Book | 3.02 x | 1.14 x | 0.35 x | - | - | - |
| Nbr of stocks (in thousands) | 5,612 | 7,652 | 8,890 | 9,554 | 9,945 | - |
| Reference price 2 | 204.9 | 56.85 | 10.45 | 13.34 | 10.15 | 10.15 |
| Announcement Date | 3/8/21 | 3/15/22 | 3/16/23 | 3/14/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 877.4 | 1,062 | 631.7 | 734.7 | 742.3 | 780.2 |
| EBITDA 1 | 271 | 33.82 | -129.8 | 75.09 | 77.4 | 85.72 |
| EBIT 1 | -64.55 | -489.4 | -318.7 | -81.68 | -49.92 | -36.33 |
| Operating Margin | -7.36% | -46.07% | -50.45% | -11.12% | -6.72% | -4.66% |
| Earnings before Tax (EBT) 1 | -97.16 | -534.2 | -375.6 | -151.1 | -116 | -101.3 |
| Net income 1 | -44.27 | -189.4 | -148.7 | -63.26 | -50.06 | -43.79 |
| Net margin | -5.05% | -17.82% | -23.54% | -8.61% | -6.74% | -5.61% |
| EPS 2 | -3.300 | -26.85 | -17.72 | -7.190 | -5.310 | -4.440 |
| Free Cash Flow 1 | -128.7 | -318.8 | 47.39 | - | 78.48 | 93.86 |
| FCF margin | -14.67% | -30.01% | 7.5% | - | 10.57% | 12.03% |
| FCF Conversion (EBITDA) | - | - | - | - | 101.4% | 109.49% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/8/21 | 3/15/22 | 3/16/23 | 3/14/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 211.7 | 449.6 | 270.6 | 158.7 | 133.1 | 69.38 | 183.2 | 142.8 | 132 | 276.7 | 178.8 | 142.3 | 130.7 | 290.2 | 195 |
| EBITDA 1 | -14.07 | 1.499 | 11.07 | -31.74 | -14.33 | -94.78 | 28.78 | 0.788 | -11.48 | 57 | 23.3 | -18.3 | -7.8 | 80.2 | - |
| EBIT 1 | -48.62 | -423.3 | -25.31 | -76.05 | -59.14 | -133.2 | -5.749 | -53.02 | -37.98 | 15.06 | -5.2 | -41.02 | -41.05 | 38.9 | 6.55 |
| Operating Margin | -22.96% | -94.15% | -9.35% | -47.93% | -44.45% | -191.97% | -3.14% | -37.13% | -28.76% | 5.44% | -2.91% | -28.82% | -31.41% | 13.4% | 3.36% |
| Earnings before Tax (EBT) 1 | -55.51 | -432.2 | -36.77 | -113.8 | -74.65 | -150.4 | -22.59 | -70.3 | -56.31 | -1.915 | -22.55 | -58.02 | -57.35 | 22.8 | -8.45 |
| Net income 1 | -20.18 | -155.1 | -13.48 | -43.82 | -30 | -61.4 | -9.179 | -28.94 | -23.91 | -1.226 | -9.87 | -25.2 | -24.81 | 9.795 | -3.759 |
| Net margin | -9.53% | -34.5% | -4.98% | -27.62% | -22.55% | -88.5% | -5.01% | -20.27% | -18.11% | -0.44% | -5.52% | -17.7% | -18.98% | 3.37% | -1.93% |
| EPS 2 | -2.700 | -20.25 | -1.800 | -5.250 | -3.450 | -7.000 | -1.120 | -3.270 | -2.610 | -0.1500 | -0.9967 | -2.683 | -2.507 | 0.5333 | -0.4900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/9/21 | 3/15/22 | 5/10/22 | 8/15/22 | 11/10/22 | 3/16/23 | 5/8/23 | 8/10/23 | 11/9/23 | 3/14/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt | 256 | 586 | 494 | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.9458 x | 17.33 x | -3.804 x | - | - | - |
| Free Cash Flow 1 | -129 | -319 | 47.4 | - | 78.5 | 93.9 |
| ROE (net income / shareholders' equity) | -7.15% | -51.6% | -47.8% | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | 67.80 | 50.00 | 30.00 | - | - | - |
| Cash Flow per Share | - | -42.30 | 7.210 | - | - | - |
| Capex 1 | 14.5 | - | 13.5 | 13.7 | 16 | 16 |
| Capex / Sales | 1.66% | - | 2.14% | 1.87% | 2.16% | 2.05% |
| Announcement Date | 3/8/21 | 3/15/22 | 3/16/23 | 3/14/24 | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.15
USD
Average target price
18.33
USD
Spread / Average Target
+80.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.91% | 101M | |
| +4.10% | 51.16B | |
| +4.04% | 25.66B | |
| +14.55% | 23.24B | |
| +26.59% | 9.56B | |
| +13.76% | 5.81B | |
| -4.12% | 4.02B | |
| +1.30% | 1.99B | |
| +11.16% | 1.76B | |
| -26.78% | 1.4B |
- Stock Market
- Equities
- GOCO Stock
- Financials GoHealth, Inc.
